3,182 hedge funds and large institutions have $196B invested in Pfizer in 2022 Q1 according to their latest regulatory filings, with 156 funds opening new positions, 1,374 increasing their positions, 1,338 reducing their positions, and 183 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less call options, than puts

Call options by funds: $ | Put options by funds: $

less funds holding

Funds holding:

12% less capital invested

Capital invested by funds: $222B → $196B (-$25.8B)

15% less first-time investments, than exits

New positions opened: 156 | Existing positions closed: 183

34% less funds holding in top 10

Funds holding in top 10: 249165 (-84)

Holders
3,182
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
165
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.18B
Puts
$3.23B
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
126
$156M
127
$153M
128
$150M
129
$150M
130
$143M
131
$143M
132
$143M
133
$140M
134
$137M
135
$137M
136
$136M
137
$132M
138
$128M
139
$127M
140
$124M
141
$123M
142
$123M
143
$122M
144
$122M
145
$122M
146
$119M
147
$118M
148
$117M
149
$117M
150
$114M